Evidence Files
Vitamin D: The Supplement Everyone Takes and the Evidence Nobody Talks About
One in three adults in Northern Europe has insufficient vitamin D levels. Governments recommend supplementation. Doctors prescribe it routinely. And yet the VITAL trial — 25,000 participants, $45 million budget — found that vitamin D supplements don't meaningfully reduce cancer or cardiovascular events in people who aren't severely deficient. The evidence is more complicated than the marketing.
Verdict
TREATMENT (partially confirmed)
We searched PubMed and Cochrane Library for vitamin D evidence. The picture is clear in one direction: correcting genuine deficiency prevents serious conditions like rickets and osteomalacia, reduces fall risk in deficient elderly, and supports immune function. What's less supported: supplementation in people with adequate levels preventing cancer, cardiovascular disease, depression, or cognitive decline.
Why supplementation became the default
Vitamin D deficiency is genuinely common in Northern Europe — shorter days, indoor lifestyles, and sun-protective behaviour mean many people don't synthesise enough through skin exposure. Observational studies showed that low vitamin D levels correlated with higher rates of cancer, cardiovascular disease, diabetes, and depression. The logical leap: supplement it and those rates will fall.
That leap turned out to be more complicated than it looked. Correlation in observational studies doesn't reliably translate to causation in randomised trials. Low vitamin D might be a marker of poor health rather than its cause — sick people go outside less, eat less diversely, and have lower vitamin D as a result.
The large RCTs that followed — VITAL, D-HEALTH, FIND, ViDA — tested supplementation in people with normal or near-normal levels. The results were largely disappointing for the headline claims.
Where the evidence is strong vs. where it falls short
- Deficiency correction — clear evidence: prevents rickets in children, osteomalacia in adults, reduces fall risk in deficient elderly; this is not in question
- Cancer prevention — VITAL (25,000 participants): no significant reduction in cancer incidence; modest reduction in cancer mortality after 2 years seen in sub-analysis
- Cardiovascular disease — VITAL: no reduction in heart attacks or stroke in healthy adults without deficiency
- Depression — multiple RCTs show no significant effect in people without deficiency; small signals in severely deficient populations
- COVID-19 — numerous trials, mostly negative; WHO does not recommend vitamin D for treatment or prevention of COVID-19
- Immune function — some evidence for reduction of respiratory infections specifically in deficient individuals; less clear for general supplementation
What the supplement industry claims vs. what the evidence shows
Common marketing claims
"Supports immune health, bone health, mood, and energy." "Essential for Northern European winters." "Most people are deficient." Often sold at doses of 1,000-4,000 IU/day for general wellness.
What the evidence shows
Bone health in genuinely deficient people: supported. Immune health in genuinely deficient people: some evidence. Mood, energy, cancer prevention, cardiovascular health in adequately-nourished people: large RCTs showed minimal or no benefit. Test your level before supplementing.
Our Conclusion
Vitamin D is real medicine for people who actually lack it. The case for routine supplementation in people with adequate levels — particularly for cancer prevention, cardiovascular health, and mood — has not survived large, well-designed trials. The honest recommendation: get a blood test. If you're deficient, supplement with guidance on dose. If you're not, the evidence doesn't support supplementing for disease prevention. The sun is free.
This article is for informational purposes only and does not constitute medical advice. Trick or Treatment analyses the presence of clinical studies in open scientific databases — PubMed and Cochrane Library. The absence of studies in these databases does not automatically mean a drug is ineffective, but it does mean its effectiveness has not been confirmed by evidence-based medicine standards. Any treatment decisions should be made together with your doctor.